Raymond James Financial Services Advisors, Inc. Axsome Therapeutics, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 15,379 shares of AXSM stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,379
Previous 15,627
1.59%
Holding current value
$1.69 Million
Previous $1.26 Million
9.86%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AXSM
# of Institutions
409Shares Held
36.6MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$426 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$363 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$321 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$186 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$107 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.71B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...